<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta />
    <article-meta>
      <title-group>
        <article-title>Accelerating Implementation of Artificial Intelligence in Radiotherapy through Explainability⋆</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <string-name>Luca Heising</string-name>
          <email>l.m.heising@tilburguniversity.edu</email>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <aff id="aff0">
          <label>0</label>
          ,
          <addr-line>Maastricht, NL</addr-line>
        </aff>
        <aff id="aff1">
          <label>1</label>
          <institution>Department of Economics and Management (TiSEM), Tilburg University</institution>
          ,
          <addr-line>Tilburg, NL</addr-line>
        </aff>
        <aff id="aff2">
          <label>2</label>
          <institution>Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre</institution>
        </aff>
      </contrib-group>
      <abstract>
        <p>To enhance the radiotherapy workflow, many artificial intelligence (AI) applications have been proposed. To date, only a limited number of the proposed AI applications have been implemented into clinical practice. Lack of trust is often mentioned as the limiting factor due to the inherent black-box characteristics of AI. Explainable AI (xAI) methods are being introduced as tool to alleviate the lack of trust in these non-transparent systems. To study the efect that xAI has on clinicians' trust, a survey was developed and distributed. Preliminary findings conclude that clinicians do not necessarily mistrust AI, yet, they seem to find transparency important. xAI could serve as a shared mental model (SMM) between the clinician and AI to maximize human-AI collaboration. Future work will look at the role that xAI plays in SMMs and how xAI must be designed to fully exploit AI for radiotherapy whilst remaining safe and ethical.</p>
      </abstract>
      <kwd-group>
        <kwd>eol&gt;Radiotherapy</kwd>
        <kwd>Implementation</kwd>
        <kwd>Healthcare</kwd>
        <kwd>Trust</kwd>
        <kwd>xAI design</kwd>
        <kwd>Shared Mental Models</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec-1">
      <title>1. Introduction</title>
      <p>
        In previous years, artificial intelligence (AI) has gained its place in the spotlight to optimize
healthcare processes [
        <xref ref-type="bibr" rid="ref1">1</xref>
        ]. The promise of AI is large, with many applications proposed to aid
clinicians in their work, among which in radiotherapy. The recent advancements in AI can
be attributed, in part, to Deep Learning (DL) algorithms, a subset of AI that utilizes multiple
hidden layers to discern patterns from input data. Deep Learning allows for accurate pattern
recognition in large datasets, engendering the opportunity to optimize healthcare workflows
and provide aid in labor-intensive tasks. In the radiotherapy workflow, AI has been proposed for
every step of the workflow. Examples of radiotherapy-related AI applications relatively high on
the technology readiness level scale are automated delineation of anatomic contours and tumors,
automated treatment planning systems, and medical imaging quality improvement algorithms.
One of the applications where AI has been proven to be a promising solution is treatment error
detection to facilitate adaptive radiotherapy (ART) [
        <xref ref-type="bibr" rid="ref2">2</xref>
        ], which is especially interesting for a
group of lung cancer patients (limited-stage small cell lung cancer) as they respond well to
radiotherapy treatment. Yet, the implementation of AI is lagging behind, partly because AI has
not been fully embraced by clinicians as AI poses additional risks [
        <xref ref-type="bibr" rid="ref3">3</xref>
        ]. For example, due to the
hidden layers of deep neural networks, the outcome of the AI can be dificult to understand
and/or interpret, and thus challenging to verify. This phenomenon is often described as the
black box; what goes into the network and what comes out can be observed, but not what
happens inside and why.
      </p>
      <p>In addition to hurdles in risks and regulation, developers and clinicians are currently often
working in silos, which can result in a delay in the implementation of relevant AI tools in
clinical practice as they do not meet the exact needs of the clinician or the clinician is unaware
of the full potential of these tools. Despite the challenges posed by AI, being overly careful with
its development and implementation can lead to underuse and missing out on cost- and
qualityimprovement opportunities. To bridge the gap between development and implementation
and to enable the safe implementation of transparent AI in radiotherapy, the current PhD
project investigates how xAI can contribute to safe and ethical implementation of AI whilst
fully exploiting its opportunities for radiotherapy. The end product of the project aims to
deliver guidelines on how to maximize collaborative performance through design of xAI in
radiotherapy.</p>
    </sec>
    <sec id="sec-2">
      <title>2. Research motivation</title>
      <p>
        Radiotherapy is a highly quantitative field in healthcare which requires high precision. The use
of technology is high, and professionals in this field are used to computational modelling. For this
reason, radiotherapy presents an appropriate setting to implement AI as it is expected that the
skepticism towards AI is relatively low compared to other fields in healthcare. The introduction
of AI could potentially optimize workflows, increase eficiency, and allow for standardization
of care, which is requested as the work pressure is increasing and world health organization
expects a deficit of over 10 million healthcare workers by 2030. As of today, AI applications
have been proposed for every step of the radiotherapy workflow, yet, the implementation is
falling behind. Amongst other barriers, the black box characteristics [
        <xref ref-type="bibr" rid="ref4 ref5">4, 5</xref>
        ] and lack of trust in
AI [
        <xref ref-type="bibr" rid="ref6 ref7 ref8">6, 7, 8</xref>
        ] are mentioned as important barriers to the implementation of AI. This is especially
troublesome for the small group of small cell lung cancer patients that depend on AI as the
adaption is mostly significant to this group of patients. xAI aims at opening up this black box
and at the same time increasing trust in AI, fostering the AI-clinician collaboration. Design
of xAI asks for a diferent approach than the design of regular AI algorithms as it serves as a
bridge between the algorithm and the user. The literature is scarce on how the design of this
translation between AI and humans can best be done and how this may difer between diferent
user groups.
      </p>
    </sec>
    <sec id="sec-3">
      <title>3. Key related work that frames your research</title>
      <sec id="sec-3-1">
        <title>3.1. Key xAI concepts and definitions</title>
        <p>Although the literature wields diferent definitions for concepts related to explainable AI (xAI),
we distinguish three main concepts; explainability, interpretability, and transparency, where
explainability and interpretability both contribute to the AI’s transparency.</p>
        <p>
          The AI model is explainable if it is clear how the model came to its prediction. A decision tree
can, thus, be considered more explainable than for example a deep neural network. The outcome
is interpretable if it is clear why the model outputs a certain prediction, for example, by providing
information on which features were most important for the model’s prediction. A model is
considered transparent if it is by itself understandable [
          <xref ref-type="bibr" rid="ref9">9</xref>
          ]. Yet, these definitions do not reveal
anything about the quality of the xAI method, which is based on the user and relates to
humanai interaction. Diferent layers to consider in xAI are philosophical foundations of what an
explanation is, social attribution of the explanation, the cognitive processes underpinning how
people explain and evaluate explanations, and social explanations or how people communicate
their explanations [
          <xref ref-type="bibr" rid="ref10">10</xref>
          ].
        </p>
      </sec>
      <sec id="sec-3-2">
        <title>3.2. Trust in AI</title>
        <p>
          Trust plays a large role in the adoption of technology as it afects both perceived usefulness
and perceived ease of use [
          <xref ref-type="bibr" rid="ref11">11</xref>
          ], the two main drivers of technology acceptance (TAM). Many
methods proposing xAI or implementing xAI argue that lack of trust is one of the main barriers
for AI adoption and that opening up the black box that is AI should ameliorate the lack of trust
[
          <xref ref-type="bibr" rid="ref12 ref13 ref14">12, 13, 14</xref>
          ]. Trust is, however, a complex concept which is influenced by many factors. It is yet
unclear how xAI plays a role in trust or lack thereof.
        </p>
        <p>Trust is a fundamental aspect in the decision making process [15]. Yet, trust is an ill-defined
concept with diferent meanings in diferent disciplines. The meaning of trust in computing is
defined as follows: “Estimated subjective probability that an entity exhibits reliable behavior
for particular operation(s) under a situation with potential risks” . Several factors play a role in
the outcome of trust such as belief, experience, rationality, uncertainty, reliability, and more
[15]. Recently, a conceptual model of trust, perceived risk and reliance on AI was proposed
[16]. This framework lays out diferent actors of trust in an AI decision aid. Transparency of AI
is, however, not covered by the proposed framework. Previous work found that increasing AI
transparency concurrently increases trust in AI [17], [18]. Our work argues that transparency
mediates the feeling of control over AI. The amended conceptual model on trust in AI, including
AI transparency (Figure 1). In the regarding PhD research, we study the efect of AI transparency
on perceived control and on trust in AI from clinicians in radiotherapy and radiology.</p>
        <sec id="sec-3-2-1">
          <title>3.2.1. Perceived trustworthiness</title>
          <p>Perceived trustworthiness is determined by many diferent characteristics, including
specifications of the AI itself. This includes the input, process and outcome of the AI, where the outcome
can be represented in the form of an AI metric such as accuracy. Other factors afecting the
perceived trustworthiness relate to external factors such as organizational context, personal
identity, and many more.</p>
        </sec>
        <sec id="sec-3-2-2">
          <title>3.2.2. Perceived control</title>
          <p>According to the previously proposed conceptual framework on trust, the trust in AI is moderated
by the perceived control over AI [16]. xAI allows the user to maintain human oversight influences
users’ perceived control over AI. This was, however, not yet tested before.</p>
          <p>In literature, in the majority of studies, trust is discussed in the context of under-trust. On the
other hand, overly trusting AI can potentially lead to harmful outcomes as well. Inappropriate
trust in AI could potentially lead clinicians in the wrong direction and a major drawback of
AI its confidence in its predictions. In the long run, a brain drain may occur as clinicians are
not required to perform the tasks themselves anymore. The lack of knowledge might result in
situations where the user is not capable of evaluating the AI output.</p>
          <p>With this framework, we examine trust in AI from a perspective of under trust, it is not clear
what the impact of too much trust in AI can have. Future work also aims to look at the impact
of too much trust in AI and how xAI can play a role finding the equilibrium between over- and
under-trust.</p>
        </sec>
      </sec>
      <sec id="sec-3-3">
        <title>3.3. xAI design</title>
        <p>Mental models are knowledge structures to describe, explain and predict the world around them
[19]. Shared mental models (SMM) refer to how individual tasks and team tasks are described,
explained and predicted by members of that team. The quality of a shared mental model is
related to team performance. For human-AI collaboration, an SMM be helpful in increasing the
team performance of human-AI collaboration. According to Andrews et al. (2023) [19], xAI can
serve as a method for SMM formation and elicitation.</p>
        <p>To establish human-centered design, close collaboration with users from the beginning of
the design process is required [20]. For traditional technology, the technology readiness level
reveals information about the maturity of certain technology and what steps must be considered
for implementation into practice. More recently, a similar scale was proposed to establish the
technology readiness level of machine learning algorithms [21] This is a ten step workflow
starting at first principles, which is purely research based, up to the last level: deployment.</p>
      </sec>
    </sec>
    <sec id="sec-4">
      <title>4. Specific research questions, hypothesis and objectives</title>
      <p>With the PhD research we aim to investigate how xAI can contribute to the safe implementation
of artificial intelligence for a synergistic collaboration between professionals in radiotherapy
and AI. As multiple user-groups in radiotherapy will use AI, we will research how AI can
contribute to all of these groups and how the communication in the form of xAI may difer
between the diferent users. To reach these goals, the following research questions were drawn
up for the start-up phase of the PhD:</p>
      <p>How is trust in AI afected by xAI from the perspective of radiologist and radiotherapist?
What are opportunities and challenges regarding xAI for radiotherapy? (systematic literature
review)</p>
      <p>How can xAI serve as a mental model for human-centric AI design for diferent user groups in
radiotherapy from a design perspective?</p>
    </sec>
    <sec id="sec-5">
      <title>5. Research approach, methods, and rationale for testing the research hypothesis</title>
      <p>This PhD research aims at studying how xAI can contribute to the implementation and adoption
of AI in radiotherapy.</p>
      <sec id="sec-5-1">
        <title>5.1. Survey on trust in AI</title>
        <p>To study trust in AI, extension of the conceptual framework for trust in AI is made. We argue
that xAI allows for higher perceived control over the AI, thereby increasing trust in AI. To
measure this, we developed a survey and distributed the survey amongst all professionals
in radiotherapy and radiology through newsletters and snowballing. After two months, the
number of responses saturated at 206 respondents.</p>
        <p>For every construct of the conceptual framework, we developed several survey questions. All
questions were validated by performing a pilot study with professionals from every participant
group. The content validity was measured using the content validity index (CVI), the participants
from the pilot study where asked to fill out a 5-point likert scale on how relevant that specific
question was. In total, ten people participated in the pilot study, of which five radiation
oncologists, two RTTs, two clinical therapists and one radiologist. Questions receiving a 2 or
lower on the CVI were removed or adjusted. The data will be analyzed using structural equation
modelling.</p>
      </sec>
      <sec id="sec-5-2">
        <title>5.2. Systematic literature review on xAI in radiotherapy</title>
        <p>The second research question will be answered by performing a systematic literature review.
Inclusion criteria for the search strategy included all deep learning application in the
radiotherapy workflow that applied some sort of xAI method. In total, the search led to 420 results, and
after filtering according to the PRISMA flow diagram ended up with 180 articles.</p>
      </sec>
      <sec id="sec-5-3">
        <title>5.3. Development explainable AI framework</title>
        <p>For the development of an explainable AI framework, we stick to the design science research
approach [22]. Stakeholders of the dose-guided radiotherapy workflow are Radiotherapy
oncologists (RTO), Medical physicists (MP), Lab technicians (RTT), and AI Developers. Each of these
groups has a diferent set of tasks and responsibilities requiring diferent information. A large
part of the DGRT workflow is laborious due to the large false positive rates. The information
used to assess the dose diferences include the PDIs and CBCT. Although less interpretable, the
PDI holds more information as this is a direct measurement of the dose given to the patient
and allows for the detection of machine-related treatment errors besides positioning errors and
anatomical errors visible in the CBCT.</p>
        <p>A focus group was set up to commonly establish the automation potential of the DGRT
workflow and the degree of augmentation per user group. Three separate sessions were held:
one with MPs, one with RTOs, and one with RTTs. During the session, the participants pointed
out where the workflow bottlenecks occur and prioritized these bottlenecks. Further steps
include a five-day design sprint with professionals in the field to design the xAI solution and
establish the requirements. The sprint will be followed by a feedback round with the individual
user groups.</p>
      </sec>
    </sec>
    <sec id="sec-6">
      <title>6. Results and contributions to date</title>
      <p>To date, the survey on trust in AI has been developed and distributed. As mentioned before, 206
respondents filled out the survey. The first analyses revealed that trust in AI does not seem to
be lacking in radiotherapy, on the contrary, most respondents seem to have high trust in AI.
Yet, interpretability of AI is not unwelcome, which would suggest that the xAI does not only
serve as a trust generator. These findings should be interpreted cautiously as the analyses are
not completed or based on testing.</p>
    </sec>
    <sec id="sec-7">
      <title>7. Expected next steps and final contribution to knowledge</title>
      <p>The next steps for the PhD study include developing an xAI governance framework for data
governance, xAI development and deployment, and (x)AI implementation and adoption.
Additionally, the guidelines which will be derived from the systematic literature review will be
tested in a clinical setting for error detection in dose-guided radiotherapy.
[15] J.-H. Cho, K. Chan, S. Adali, A survey on trust modeling, ACM Computing Surveys (CSUR)
48 (2015) 1–40.
[16] E. Solberg, M. Kaarstad, M. H. R. Eitrheim, R. Bisio, K. Reegård, M. Bloch, A conceptual
model of trust, perceived risk, and reliance on ai decision aids, Group &amp; Organization
Management 47 (2022) 187–222.
[17] E. Glikson, A. W. Woolley, Human trust in artificial intelligence: Review of empirical
research, Academy of Management Annals 14 (2020) 627–660.
[18] D. Shin, The efects of explainability and causability on perception, trust, and acceptance:
Implications for explainable ai, International Journal of Human-Computer Studies 146
(2021) 102551.
[19] R. W. Andrews, J. M. Lilly, D. Srivastava, K. M. Feigh, The role of shared mental models in
human-ai teams: a theoretical review, Theoretical Issues in Ergonomics Science 24 (2023)
129–175.
[20] H. Chen, C. Gomez, C.-M. Huang, M. Unberath, Explainable medical imaging ai needs
human-centered design: guidelines and evidence from a systematic review, NPJ digital
medicine 5 (2022) 156.
[21] A. Lavin, C. M. Gilligan-Lee, A. Visnjic, S. Ganju, D. Newman, S. Ganguly, D. Lange, A. G.</p>
      <p>Baydin, A. Sharma, A. Gibson, et al., Technology readiness levels for machine learning
systems, Nature Communications 13 (2022) 6039.
[22] A. Hevner, S. Chatterjee, A. Hevner, S. Chatterjee, Design science research in information
systems, Design research in information systems: theory and practice (2010) 9–22.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ref1">
        <mixed-citation>
          [1]
          <string-name>
            <given-names>F.</given-names>
            <surname>Jiang</surname>
          </string-name>
          ,
          <string-name>
            <given-names>Y.</given-names>
            <surname>Jiang</surname>
          </string-name>
          ,
          <string-name>
            <given-names>H.</given-names>
            <surname>Zhi</surname>
          </string-name>
          ,
          <string-name>
            <given-names>Y.</given-names>
            <surname>Dong</surname>
          </string-name>
          ,
          <string-name>
            <given-names>H.</given-names>
            <surname>Li</surname>
          </string-name>
          ,
          <string-name>
            <given-names>S.</given-names>
            <surname>Ma</surname>
          </string-name>
          ,
          <string-name>
            <given-names>Y.</given-names>
            <surname>Wang</surname>
          </string-name>
          ,
          <string-name>
            <given-names>Q.</given-names>
            <surname>Dong</surname>
          </string-name>
          ,
          <string-name>
            <given-names>H.</given-names>
            <surname>Shen</surname>
          </string-name>
          ,
          <string-name>
            <given-names>Y.</given-names>
            <surname>Wang</surname>
          </string-name>
          ,
          <article-title>Artificial intelligence in healthcare: past, present and future</article-title>
          ,
          <source>Stroke and vascular neurology 2</source>
          (
          <year>2017</year>
          ).
        </mixed-citation>
      </ref>
      <ref id="ref2">
        <mixed-citation>
          [2]
          <string-name>
            <given-names>C. J.</given-names>
            <surname>Wolfs</surname>
          </string-name>
          ,
          <string-name>
            <given-names>R. A.</given-names>
            <surname>Canters</surname>
          </string-name>
          ,
          <string-name>
            <given-names>F.</given-names>
            <surname>Verhaegen</surname>
          </string-name>
          ,
          <article-title>Identification of treatment error types for lung cancer patients using convolutional neural networks and epid dosimetry</article-title>
          ,
          <source>Radiotherapy and Oncology</source>
          <volume>153</volume>
          (
          <year>2020</year>
          )
          <fpage>243</fpage>
          -
          <lpage>249</lpage>
          . URL: https://www.sciencedirect.com/science/ article/pii/S0167814020308239. doi:https://doi.org/10.1016/j.radonc.
          <year>2020</year>
          .
          <volume>09</volume>
          . 048, physics Special Issue:
          <source>ESTRO Physics Research Workshops on Science in Development.</source>
        </mixed-citation>
      </ref>
      <ref id="ref3">
        <mixed-citation>
          [3]
          <string-name>
            <given-names>O.</given-names>
            <surname>Asan</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A. E.</given-names>
            <surname>Bayrak</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A.</given-names>
            <surname>Choudhury</surname>
          </string-name>
          ,
          <article-title>Artificial intelligence and human trust in healthcare: focus on clinicians</article-title>
          ,
          <source>Journal of medical Internet research 22</source>
          (
          <year>2020</year>
          )
          <article-title>e15154</article-title>
          .
        </mixed-citation>
      </ref>
      <ref id="ref4">
        <mixed-citation>
          [4]
          <string-name>
            <given-names>C.</given-names>
            <surname>Fiorino</surname>
          </string-name>
          ,
          <string-name>
            <given-names>R.</given-names>
            <surname>Jeraj</surname>
          </string-name>
          ,
          <string-name>
            <given-names>C. H.</given-names>
            <surname>Clark</surname>
          </string-name>
          ,
          <string-name>
            <given-names>C.</given-names>
            <surname>Garibaldi</surname>
          </string-name>
          ,
          <string-name>
            <given-names>D.</given-names>
            <surname>Georg</surname>
          </string-name>
          ,
          <string-name>
            <given-names>L.</given-names>
            <surname>Muren</surname>
          </string-name>
          , W. van Elmpt,
          <string-name>
            <given-names>T.</given-names>
            <surname>Bortfeld</surname>
          </string-name>
          ,
          <string-name>
            <given-names>N.</given-names>
            <surname>Jornet</surname>
          </string-name>
          ,
          <article-title>Grand challenges for medical physics in radiation oncology</article-title>
          ,
          <source>Radiotherapy and Oncology</source>
          <volume>153</volume>
          (
          <year>2020</year>
          )
          <fpage>7</fpage>
          -
          <lpage>14</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref5">
        <mixed-citation>
          [5]
          <string-name>
            <given-names>L.</given-names>
            <surname>Arbelaez Ossa</surname>
          </string-name>
          , G. Starke, G. Lorenzini,
          <string-name>
            <given-names>J. E.</given-names>
            <surname>Vogt</surname>
          </string-name>
          ,
          <string-name>
            <given-names>D. M.</given-names>
            <surname>Shaw</surname>
          </string-name>
          ,
          <string-name>
            <given-names>B. S.</given-names>
            <surname>Elger</surname>
          </string-name>
          ,
          <article-title>Re-focusing explainability in medicine</article-title>
          ,
          <source>Digital health 8</source>
          (
          <year>2022</year>
          )
          <fpage>20552076221074488</fpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref6">
        <mixed-citation>
          [6]
          <string-name>
            <given-names>F.</given-names>
            <surname>Cabitza</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A.</given-names>
            <surname>Campagner</surname>
          </string-name>
          ,
          <string-name>
            <surname>C.</surname>
          </string-name>
          <article-title>Balsano, Bridging the “last mile” gap between ai implementation and operation:“data awareness” that matters</article-title>
          ,
          <source>Annals of translational medicine 8</source>
          (
          <year>2020</year>
          ).
        </mixed-citation>
      </ref>
      <ref id="ref7">
        <mixed-citation>
          [7]
          <string-name>
            <given-names>L.</given-names>
            <surname>Petersson</surname>
          </string-name>
          ,
          <string-name>
            <surname>I. Larsson</surname>
          </string-name>
          ,
          <string-name>
            <given-names>J. M.</given-names>
            <surname>Nygren</surname>
          </string-name>
          ,
          <string-name>
            <given-names>P.</given-names>
            <surname>Nilsen</surname>
          </string-name>
          ,
          <string-name>
            <given-names>M.</given-names>
            <surname>Neher</surname>
          </string-name>
          ,
          <string-name>
            <given-names>J. E.</given-names>
            <surname>Reed</surname>
          </string-name>
          ,
          <string-name>
            <given-names>D.</given-names>
            <surname>Tyskbo</surname>
          </string-name>
          ,
          <string-name>
            <given-names>P.</given-names>
            <surname>Svedberg</surname>
          </string-name>
          ,
          <article-title>Challenges to implementing artificial intelligence in healthcare: a qualitative interview study with healthcare leaders in sweden</article-title>
          ,
          <source>BMC Health Services Research</source>
          <volume>22</volume>
          (
          <year>2022</year>
          )
          <fpage>1</fpage>
          -
          <lpage>16</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref8">
        <mixed-citation>
          [8]
          <string-name>
            <given-names>F.</given-names>
            <surname>Gama</surname>
          </string-name>
          ,
          <string-name>
            <given-names>D.</given-names>
            <surname>Tyskbo</surname>
          </string-name>
          ,
          <string-name>
            <given-names>J.</given-names>
            <surname>Nygren</surname>
          </string-name>
          ,
          <string-name>
            <given-names>J.</given-names>
            <surname>Barlow</surname>
          </string-name>
          ,
          <string-name>
            <given-names>J.</given-names>
            <surname>Reed</surname>
          </string-name>
          ,
          <string-name>
            <given-names>P.</given-names>
            <surname>Svedberg</surname>
          </string-name>
          ,
          <article-title>Implementation frameworks for artificial intelligence translation into health care practice: scoping review</article-title>
          ,
          <source>Journal of Medical Internet Research</source>
          <volume>24</volume>
          (
          <year>2022</year>
          )
          <article-title>e32215</article-title>
          .
        </mixed-citation>
      </ref>
      <ref id="ref9">
        <mixed-citation>
          [9]
          <string-name>
            <given-names>A. B.</given-names>
            <surname>Arrieta</surname>
          </string-name>
          ,
          <string-name>
            <given-names>N.</given-names>
            <surname>Díaz-Rodríguez</surname>
          </string-name>
          ,
          <string-name>
            <given-names>J. Del</given-names>
            <surname>Ser</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A.</given-names>
            <surname>Bennetot</surname>
          </string-name>
          ,
          <string-name>
            <given-names>S.</given-names>
            <surname>Tabik</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A.</given-names>
            <surname>Barbado</surname>
          </string-name>
          ,
          <string-name>
            <given-names>S.</given-names>
            <surname>García</surname>
          </string-name>
          ,
          <string-name>
            <given-names>S.</given-names>
            <surname>Gil-López</surname>
          </string-name>
          ,
          <string-name>
            <given-names>D.</given-names>
            <surname>Molina</surname>
          </string-name>
          ,
          <string-name>
            <given-names>R.</given-names>
            <surname>Benjamins</surname>
          </string-name>
          , et al.,
          <article-title>Explainable artificial intelligence (xai): Concepts, taxonomies, opportunities and challenges toward responsible ai</article-title>
          ,
          <source>Information fusion 58</source>
          (
          <year>2020</year>
          )
          <fpage>82</fpage>
          -
          <lpage>115</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref10">
        <mixed-citation>
          [10]
          <string-name>
            <given-names>A.</given-names>
            <surname>Angelopoulou</surname>
          </string-name>
          ,
          <string-name>
            <given-names>E.</given-names>
            <surname>Kapetanios</surname>
          </string-name>
          ,
          <string-name>
            <given-names>D. H.</given-names>
            <surname>Smith</surname>
          </string-name>
          ,
          <string-name>
            <given-names>V.</given-names>
            <surname>Steuber</surname>
          </string-name>
          ,
          <string-name>
            <given-names>B.</given-names>
            <surname>Woll</surname>
          </string-name>
          ,
          <string-name>
            <given-names>F.</given-names>
            <surname>Zeller</surname>
          </string-name>
          ,
          <article-title>Explanation in human-ai systems</article-title>
          ,
          <source>Frontiers in Artificial Intelligence</source>
          <volume>5</volume>
          (
          <year>2022</year>
          )
          <fpage>1048568</fpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref11">
        <mixed-citation>
          [11]
          <string-name>
            <given-names>P. A.</given-names>
            <surname>Pavlou</surname>
          </string-name>
          ,
          <article-title>Consumer acceptance of electronic commerce: Integrating trust and risk with the technology acceptance model</article-title>
          ,
          <source>International journal of electronic commerce 7</source>
          (
          <year>2003</year>
          )
          <fpage>101</fpage>
          -
          <lpage>134</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref12">
        <mixed-citation>
          [12]
          <string-name>
            <given-names>L.</given-names>
            <surname>Strohm</surname>
          </string-name>
          ,
          <string-name>
            <given-names>C.</given-names>
            <surname>Hehakaya</surname>
          </string-name>
          ,
          <string-name>
            <given-names>E. R.</given-names>
            <surname>Ranschaert</surname>
          </string-name>
          ,
          <string-name>
            <given-names>W. P.</given-names>
            <surname>Boon</surname>
          </string-name>
          ,
          <string-name>
            <given-names>E. H.</given-names>
            <surname>Moors</surname>
          </string-name>
          ,
          <article-title>Implementation of artificial intelligence (ai) applications in radiology: hindering and facilitating factors</article-title>
          ,
          <source>European radiology 30</source>
          (
          <year>2020</year>
          )
          <fpage>5525</fpage>
          -
          <lpage>5532</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref13">
        <mixed-citation>
          [13]
          <string-name>
            <given-names>S.</given-names>
            <surname>Reddy</surname>
          </string-name>
          ,
          <string-name>
            <given-names>S.</given-names>
            <surname>Allan</surname>
          </string-name>
          ,
          <string-name>
            <given-names>S.</given-names>
            <surname>Coghlan</surname>
          </string-name>
          ,
          <string-name>
            <given-names>P.</given-names>
            <surname>Cooper</surname>
          </string-name>
          ,
          <article-title>A governance model for the application of ai in health care</article-title>
          ,
          <source>Journal of the American Medical Informatics Association</source>
          <volume>27</volume>
          (
          <year>2020</year>
          )
          <fpage>491</fpage>
          -
          <lpage>497</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref14">
        <mixed-citation>
          [14]
          <string-name>
            <given-names>C. L.</given-names>
            <surname>Brouwer</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A. M.</given-names>
            <surname>Dinkla</surname>
          </string-name>
          ,
          <string-name>
            <given-names>L.</given-names>
            <surname>Vandewinckele</surname>
          </string-name>
          ,
          <string-name>
            <given-names>W.</given-names>
            <surname>Crijns</surname>
          </string-name>
          ,
          <string-name>
            <given-names>M.</given-names>
            <surname>Claessens</surname>
          </string-name>
          ,
          <string-name>
            <given-names>D.</given-names>
            <surname>Verellen</surname>
          </string-name>
          , W. van Elmpt,
          <article-title>Machine learning applications in radiation oncology: Current use and needs to support clinical implementation</article-title>
          ,
          <source>Physics and imaging in radiation oncology 16</source>
          (
          <year>2020</year>
          )
          <fpage>144</fpage>
          -
          <lpage>148</lpage>
          .
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>